PET/MRI and the revolution of the third eye

The 20th century diagnostic imaging scenario almost for the whole of its existence was divided into two well-separated universes: (1) the morphostructural, in which information on anatomy and structures are acquired, with pathology as the gold standard, and (2) the functional, in which normal and altered functions are analysed, with pathophysiology as the reference. Morphostructural techniques show differences in density, as observed in a picture taken in a steady state as a freezeframe effectively not allowing distinction between a living and a dead body. Functional techniques, which can only be applied in a living being, show dynamic changes as in a movie where “time” is a major element, taking information from parameters such as differences in concentration and movement. This category includes techniques such as urography and cardio-CT, in which increasing doses in dynamic scans and the number of acquisitions are important considerations [1]. To avoid a high radiation dose, the lowest number of frames are acquired, and this is a major disadvantage with respect to nuclear medicine and MRI, which are queens in “clinical” functional imaging because of their superiority in studying pathophysiology. Nuclear medicine as molecular imaging

[1]  Stefano Fanti,et al.  PET-CT beyond FDG , 2013 .

[2]  Jacques-Donald Tournier,et al.  Diffusion tensor imaging and beyond , 2011, Magnetic resonance in medicine.

[3]  Jason S. Lewis,et al.  The next generation of positron emission tomography radiopharmaceuticals in oncology. , 2011, Seminars in nuclear medicine.

[4]  Peter J. Ell,et al.  18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  N M deSouza,et al.  Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies? , 2012, British Journal of Cancer.

[6]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[7]  M C Gilardi,et al.  PET/CT for radiotherapy: image acquisition and data processing. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[8]  G. Delso,et al.  PET/MRI system design , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  P M Matthews,et al.  Guidelines for using proton MR spectroscopy in multicenter clinical MS studies , 2007, Neurology.

[10]  Z. Keidar,et al.  The fusion of anatomic and physiologic imaging in the management of patients with cancer. , 2001, Seminars in nuclear medicine.

[11]  Mathias Hoehn,et al.  Cellular MR Imaging , 2005, Molecular imaging.

[12]  Beth L Vealé,et al.  Advanced computed tomography technology and patient dose: a literature review. , 2011, Radiology management.

[13]  Thomas E Yankeelov,et al.  Magnetic resonance in the era of molecular imaging of cancer. , 2011, Magnetic resonance imaging.

[14]  A Todd-Pokropek Advances in computers and image processing with applications in nuclear medicine. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[15]  Giovanni Lucignani,et al.  PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  Bernd J. Pichler,et al.  PET/MRI hybrid imaging: devices and initial results , 2008, European Radiology.

[17]  Sophie Laurent,et al.  Classification and basic properties of contrast agents for magnetic resonance imaging. , 2009, Contrast media & molecular imaging.

[18]  Tony Abraham,et al.  Evolution of brain imaging instrumentation. , 2011, Seminars in nuclear medicine.

[19]  Flavio Nobili,et al.  Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....